3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Colorectal Neoplasms
8
Polycythemia Vera
6
Multiple Myeloma
5
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Cardiovascular Diseases
4
Venous Thromboembolism
3
Thrombocythemia, Essential
3
Precancerous Conditions
3
Ovarian Neoplasms
3
Neoplasms, Plasma Cell
3
Myeloproliferative Disorders
3
Melanoma
3
Esophageal Neoplasms
3
Barrett Esophagus
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Adenomatous Polyps
2
Vascular Diseases
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stroke
1
Interventions
Paclitaxel
37
Carboplatin
28
pembrolizumab
19
Surveys and Questionnaires
11
temsirolimus
10
Radiotherapy
10
Cisplatin
10
Doxorubicin
9
Bevacizumab
9
lenvatinib
8
Docetaxel
8
Nivolumab
7
Metformin
7
Gemcitabine
7
Early Intervention, Educational
7
Counseling
7
Sirolimus
6
Radiation
6
Megestrol Acetate
6
Indocyanine Green
6
olaparib
5
Topotecan
5
Therapeutics
5
Psychiatric Rehabilitation
5
Methods
5
Letrozole
5
Ipilimumab
5
Chemotherapy, Adjuvant
5
ridaforolimus
4
Trastuzumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Endometrial Neoplasms
×
Aspirin
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled